Myocardial Glucose Transport and Utilization in Patients With Type 2 Diabetes Mellitus, Left Ventricular Dysfunction, and Coronary Artery Disease

Journal of the American College of Cardiology

Volumn 48, Issue 11, 2006, Pages 2225-2231

  Dutka, David P ^a   Pitt, Michael ^b   Pagano, Domenico ^b   Mongillo, Marco ^b   Gathercole, David ^b   Bonser, Robert S ^b   Camici, Paolo G ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE BLOOD FLOW; HUMAN; MALE; MEMBRANE TRANSPORT; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AGED; BLOTTING, WESTERN; CARDIAC OUTPUT, LOW; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MIDDLE AGED; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33845201058     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.06.078     Document Type: Article

References (29)

1. Malmberg K., Ryden L., Hamsten A., Herlitz J., Waldenstrom A., and Wedel H. Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. Cardiovasc Res 34 (1997) 248-253
2. Malmberg K., Norhammar A., Wedel H., and Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99 (1999) 2626-2632
3. Malmberg K., DIGAMI (Diabetes Mellitus, and Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. Br Med J 314 (1997) 1512-1515
4. Camici P., Ferrannini E., and Opie L.H. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 32 (1989) 217-238
5. Slot J.W., Geuze H.J., Gigengack S., James D.E., and Lienhard G.E. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci U S A 88 (1991) 7815-7819
6. Depre C., Vanoverschelde J.L., and Taegtmeyer H. Glucose for the heart. Circulation 99 (1999) 578-588
7. Depre C., Rider M.H., and Hue L. Mechanisms of control of heart glycolysis. Eur J Biochem 258 (1998) 277-290
8. Young L.H., Renfu Y., Russell R., et al. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 95 (1997) 415-422
9. Hashimoto K., Nishimura T., Ishikawa M., et al. Enhancement of glucose uptake in stunned myocardium: role of glucose transporter. Am J Physiol 272 (1997) H1122-H1130
10. Iozzo P., Chareonthaitawee P., Dutka D., Betteridge D.J., Ferrannini E., and Camici P.G. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 51 (2002) 3020
11. Utriainen T., Takala T., Luotolahti M., et al. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM. Diabetologia 41 (1998) 555-559
12. Swan J.W., Anker S.D., Walton C., et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 30 (1997) 527-532
13. Paternostro G., Camici P.G., Lammerstma A.A., et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 98 (1996) 2094-2099
14. Paternostro G., Pagano D., Gnecchi-Ruscone T., Bonser R.S., and Camici P.G. Insulin resistance in patients with cardiac hypertrophy. Cardiovascular Res 42 (1999) 246-253
15. Pagano D., Townend J.N., Parums D., Bonser R.S., and Camici P.G. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart 83 (2000) 456-461
16. Marinho N.V., Keogh B.E., Costa D.C., Lammerstma A.A., Ell P.J., and Camici P.G. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 93 (1997) 737-744
17. 15O-water and dynamic positron emission tomography. Circulation 86 (1992) 167-178
18. Fath-Ordoubadi F., Beatt K.J., Spyrou N., and Camici P.G. Efficacy of coronary angioplasty for the treatment of hibernating myocardium. Heart 82 (1999) 210-216
19. Iozzo P., Chareonthaitawee P., Di Terlizzi M., Betteridge D.J., Ferrannini E., and Camici P.G. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. Am J Physiol Endocrinol Metab 282 (2002) E1163-E1171
20. Kudej R.K., White L.T., Kudej A.B., Vatner S.F., and Lewandowski E.D. Brief increase in carbohydrate oxidation after reperfusion reverses myocardial stunning in conscious pigs. Circulation 106 (2002) 2836-2841
21. Opie L.H., and Sack M.N. Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemic preconditioning. J Mol Cell Cardiol 34 (2002) 1077-1089
22. Ohtake T., Yokoyama I., Watanabe T., et al. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 36 (1995) 456-463
23. Voipio-Pulkki L.M., Nuutila P., Knuuti M.J., et al. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med 34 (1993) 2064-2067
24. Kainulainen H., Breiner M., Schurmann A., Marttinen A., Virjo A., and Joost H.G. In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats. Biochimica Biophysica Acta 1225 (1994) 275-282
25. Bruning J.C., Michael M.D., Winnay J.N., et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2 (1998) 559-569
26. Baldeweg S.E., Golay A., Natali A., Balkau B., Del Prato S., Coppack S.W., and European Group for the Study of Insulin Resistance (EGIR). Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. Eur J Clin Invest 30 (2000) 45-52
27. Dresner A., Laurent D., Marcucci M., et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103 (1999) 253-259
28. Yue T.L., Chen J., Bao W., et al. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-[gamma] agonist rosiglitazone. Circulation 104 (2001) 2588-2594
29. Wayman N.S., Hattori Y., McDonald M.C., et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J 16 (2002) 1027-1040